Gastroesophageal Reflux Disease (GERD) Awareness Week is observed the week of Thanksgiving, as Americans prepare to indulge in the holiday season. A Jefferson expert warns that GERD is more than a nuisance.
One virus creates a long-lived immune reaction in parts of our bodies that serve as our first line of defense against infections, making it a strong candidate for a variety of vaccines.
A routine screening could help narrow the estimated date of delivery for pregnant women.
Jefferson College of Health Professions is now accepting applications for a post-graduate certificate in medical family therapy. This growing field supports families who have been affected by a medical diagnosis or treatment within an interprofessional healthcare environment. The certificate program is a unique collaboration between Jefferson’s Department of Couple and Family Therapy and the Council for Relationships and emphasizes hands-on clinical experience.
Researchers find a protein that's involved in helping control the architecture of connections between neurons – a basic process involved in both healthy and diseased brains.
Mystical experiences are frequently labeled as indescribable or ineffable. However, new research suggests that when prompted, people who have had a mystical, spiritual or religious experience can describe the event.
When it comes to treating blood cancers like leukemia and lymphomas, new research shows that a half-matched donor bone marrow transplant may be just as good as a full match, in the first apples to apples type comparison of its kind.
Beth Schwartz joins Jefferson and Nemours as a specialist in pediatric and adolescent gynecology to help families address girls’ needs from birth to early adulthood.
Arteries contain higher numbers of circulating tumor cells than veins in uveal melanoma patients, raising a concern for standard technique for detection of tumor cells in the blood.
Jefferson researchers identified a high risk for venous thromboembolism (VTE), or blood clots, following surgery for long-bone reconstruction in patients with metastatic cancer. They published the results in the Journal of Bone and Joint Surgery.
Jefferson expands its cancer treatment to analyze each tumor with the newest techniques and help doctors identify cutting edge treatment options.
Jefferson Health has added an On-Demand Virtual Care app to its telemedicine program. The app allows patients to connect with emergency medicine physicians via computers and mobile devices.
Jefferson researchers showed that a simple questionnaire, evaluation and pulse-oximetry monitoring can lead to early detection of sleep apnea in patients hospitalized for congestive heart failure.
Many seniors with cancer are also using complementary or alternative medicines that could interfere with their cancer treatment.
New Curriculum Platform uses iPads to Meet Students Where They Are – On Mobile Devices
Edith Mitchell, M.D., Professor of Medical Oncology at Thomas Jefferson University, will be appointed as President of the National Medical Association (NMA) at the NMA’s 113th Annual Convention and Scientific Assembly in Detroit, Michigan on Tuesday August 4th.
A set of genes could help stratify African American men in need of more aggressive treatment for prostate cancer.
A multi-disciplinary group of researchers and physicians at Thomas Jefferson University and Hospitals have created a clinical pathway to identify obstructive sleep apnea in higher-risk, hospitalized patients.
A single molecule called DNA-PKcs may drive metastatic processes that turn cancer from a slowly growing relatively benign disease to a killer.
The study reports on a newly discovered category of tRNA fragments as well as shows that all tRNAs are rich sources of very diverse short molecules whose characteristics depend on a person’s gender, population, and race and differ according to tissue and disease type.
Rather than cellular trash, half of a transfer RNA (tRNA) molecule appears to actively spur cell proliferation in breast and prostate cancers, suggesting a new role for tRNA and a possible target for a new class of therapy.
Stress hormones often given to patients to treat the side effects of therapy may cause a subset of breast cancers to become treatment-resistant.
Researchers discover that a protein called Taranis could hold the key to a good night’s sleep.
A hormone that regulates blood sugar levels may be the key to reducing the risk of acute respiratory distress syndrome in obese patients.
Karen Knudsen will become the ninth woman in an illustrious group of 68 leaders of NCI-designated Cancer Centers around the nation.
A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.
A green dye that sticks to bone grafts becomes antimicrobial with the flick of a light switch and could help reduce the risk of infections during bone-reconstruction surgeries.
Researchers discover the role of a major cytokine in multiple sclerosis that could be a target for new therapy against the disease.
There has been debate in the field about whether non-medically required induction of labor leads to a greater likelihood of C-section. A new analysis found no link between induction and rates of C section in uncomplicated pregnancies.
A new type of liquid biopsy for solid tumors based on analyzing exosomes from the blood is being tested at Thomas Jefferson University.
Adults with sickle cell disease who report trouble with sleep could actually have a clinical diagnosis of sleep disordered breathing which could lower their oxygen levels at night.
Cancer patients over the age of 65 often take multiple drugs, which can interfere with cancer treatment. A new study shows that currently used tools to prevent over-medicating senior cancer patients need improvement
Researchers from Thomas Jefferson University and NIH tested for prophylactic antibiotic concentrations in joint fluid samples.
Researchers find many new gene-regulating molecules that are tissue and human specific.
Next generation chemotherapy for prostate cancer has unique properties that could make it more effective earlier in treatment if confirmed in clinical trials.
Jefferson partners with Reproductive Medicine Associates (RMA) of Philadelphia to offer fertility services at its new Center City OBGYN facility.
Grant will support Jefferson Integrative Medicine and establishes Marcus Integrative Health at the Myrna Brind Center – Villanova
Researchers find clues for reducing infections after bone marrow transplantation for leukemia and lymphoma.
To help bring a wider array of new prostate cancer therapies to patients sooner, Jefferson joins a prestigious clinical trial group, with several projects already in the works.
Jefferson Appoints Sandra Dayaratna, M.D., as Division Director of the Generalist Division of the Obstetrics and Gynecology Department
A simple technique may be most effective in preventing heart disease after radiation therapy for breast cancer.
The cause of prostate cancer may be linked to Parkinson’s disease through a common enzyme family called sirtuins.
Researchers gain new insight into how motor neurons in the brain die during ALS
The receptor CCR5, targeted by HIV drugs, is also key in driving prostate cancer metastases, suggesting that blocking this molecule could slow prostate cancer spread
Blocking molecules involved in ALS-drug resistance may improve how well ALS therapeutics work, suggesting that re-evaluation of drugs that appeared to have failed might be appropriate
Researchers debate whether the lung tissue in pulmonary fibrosis is directly damaged, or whether immune cells initiate the scarring process – an important distinction when trying to find new ways to battle the disease. Now research shows that both processes may be important, and suggest a new direction for developing novel therapies.
An anti-cancer drug protects normal cells from radiation damage and increases the effectiveness of radiation therapy in prostate cancer models
Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right